Patients with M0 stage tumors showed only CACNA1H, SLC24A3 and NALCN associated with OS differences, while ATP2A1, ATP13A2, TRPC1, and NALCN proved to be significantly associated with OS in the N1–N3 tumor stage patient subgroup. Here, ATP13A2 is linked to neoplasm.